Nicainoprol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263118This classification denotes a beta-adrenergic blocking agent with the molecular formula C21H27N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1UA960P80H, chemically known as 1,2,3,4-tetrahydro-8-(2-hydroxy-3-(isopropylamino)propoxy)-1-(3-pyridylcarbonyl)quinoline but generally known as nicainoprol, which bears US NIH Compound Identifier 71147. European Medicines Agency schedules Nicainoprol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09221MIG. The term NICAINOPROL is an International Non-Proprietary Name. NICAINOPROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicainoprol under HS 29334990 and SITC 51575. As of Q4 2014, NICAINOPROL remains the US FDA Preferred Term for this commodity. Nicainoprol bears US NLM identifiers UMLS ID C0068676 and NCI Concept Code C76553. SMILES: O(C1C2N(CCCC2CCC1)C(=O)C1CCCNC1)CC(O)CNC(C)C.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.